跳至主要内容
临床试验/IRCT20190303042903N1
IRCT20190303042903N1已完成2 期

Investigation of Metformin effect on the expression of H19, MEG3, MALAT1 and GAS5 long non-coding RNA levels in patients with type 2 diabetes: a clinical trial study

Yasouj University of Medical Sciences0 个研究点目标入组 35 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Has a fasting blood glucose level of 126 mg / dl

排除标准

  • consumer metformin or any other hypoglycemic drug and any other drug like statin, antihypertensive, anti-inflammatory drug, and an ACE inhibitor.
  • A group of patients with cardiovascular disease and inflammatory diseases (such as lupus, rheumatoid arthritis, etc.)
  • A group of patients with a variety of cancers
  • A group of type 2 of diabetes
  • Group of people with hyperlipidemia and hypertension

研究者

发起方
Yasouj University of Medical Sciences

相似试验